Catheter Precision VTAK
NYSE VTAK
$0.17 -0.02 (-10.83%)
As of: Sep 9, 2026 · 3:59 PM EDT

Catheter Precision (VTAK) Free Cash Flow Growth (3y) (2020 - 2026)

Analysis

Catheter Precision (VTAK) Free Cash Flow Growth (3y) (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 41.96%
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 24.84%
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 35.29%
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 25.48%
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 35.42%
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 250.09%
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 11.09%
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 12.01%
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 9.23%
10 Catheter Precision 480,427.59 -1.36 Mn 98,000.00 15.71%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.71%
Mar 31, 2026 38.55%
Dec 31, 2025 21.00%
Sep 30, 2025 23.78%
Jun 30, 2025 27.71%
Mar 31, 2025 35.05%
Dec 31, 2024 20.74%
Sep 30, 2024 27.72%
Jun 30, 2024 36.21%
Mar 31, 2024 37.64%
Dec 31, 2023 41.26%
Sep 30, 2023 32.93%
Jun 30, 2023 5.79%
Mar 31, 2023 -19.58%
Dec 31, 2022 31.87%
Sep 30, 2022 14.26%
Jun 30, 2022 4.10%
Mar 31, 2022 2.10%
Dec 31, 2021 13.23%
Sep 30, 2021 -19.31%